Anneli D. N.
- Country
- Denmark
- Department
- Oncology
Research Overview
- Molecularly Tailored Therapy Versus Standard Care in Advanced Pancreatic Cancer with Actionable Molecular Alterations
- Phase 3 Randomized Study of INCB161734 Plus Combination Chemotherapy Versus Placebo Plus Chemotherapy in KRAS G12D‑Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Phase 3 Randomized Trial of Daraxonrasib Monotherapy or Daraxonrasib + Gemcitabine/Nab‑Paclitaxel vs Gemcitabine/Nab‑Paclitaxel in First‑Line Metastatic Pancreatic Cancer
Data & Insights
Has run more than one trial at 43 of 124 partner sites.
Specializations
Pancreatic Oncology
The investigator specializes in the treatment of non-resectable pancreatic cancer, with particular emphasis on developing therapeutic approaches for fragile patients who require specialized treatment protocols.
- Advanced Pancreatic Cancer Management
- Personalized Treatment Strategies
- Chemotherapy Optimization
The investigator focuses on evaluating treatment efficacy in patients who may not be suitable candidates for standard aggressive therapy regimens.
Precision Medicine
Expertise in developing tailored treatment approaches for vulnerable patient populations, particularly focusing on dose modification strategies in pancreatic cancer therapy.
- Treatment Optimization
- Patient-Specific Protocols
- Risk-Adapted Therapy
The investigator's work centers on balancing treatment efficacy with patient tolerability in advanced cancer care.
Clinical Innovation
The investigator explores alternative treatment strategies for pancreatic cancer patients, with specific attention to comparing standard and modified therapeutic approaches.
- Comparative Treatment Studies
- Modified Dosing Protocols
- Patient Safety Optimization
A key focus is placed on developing evidence-based approaches for treating vulnerable patient populations with advanced pancreatic cancer.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.